These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8093295)

  • 41. Allogeneic matched T-cell-depleted bone marrow transplantation for acute leukemia patients.
    Aristei C; Aversa F; Raymondi C; Marsella AR; Panizza BM; Perrucci E; Piro F; Maranzano E; Lupattelli M; Martelli MF; Latini P
    Cancer J Sci Am; 1996; 2(6):330-4. PubMed ID: 9166553
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Immunophenotyping study of bone marrow fractions obtained by elutriation in allogeneic bone marrow transplantation].
    Merino A; Urbano-Ispizua A; Marín P; Besson I; Carreras E; Sierra J; Salgado C; Rovira M; Grañena A; Montserrat E
    Sangre (Barc); 1993 Oct; 38(5):359-64. PubMed ID: 8140496
    [TBL] [Abstract][Full Text] [Related]  

  • 43. T cell depletion in bone marrow transplantation.
    Poynton CH
    Bone Marrow Transplant; 1988 Jul; 3(4):265-79. PubMed ID: 3048492
    [TBL] [Abstract][Full Text] [Related]  

  • 44. T-cell-depleted autologous marrow fails to prevent acute graft-versus-host disease after allogeneic marrow transplantation for lymphoblastic lymphoma.
    Przepiorka D; Giralt S; Huh YO; Andreeff M; Luna M; Reading C; Thomas M; Champlin RE
    Transplant Proc; 1992 Dec; 24(6):2906-7. PubMed ID: 1465994
    [No Abstract]   [Full Text] [Related]  

  • 45. [Bone marrow transplantation for therapy of leukemia].
    Masaoka T
    Nihon Naika Gakkai Zasshi; 1992 Jul; 81(7):1060-4. PubMed ID: 1383366
    [No Abstract]   [Full Text] [Related]  

  • 46. Perspectives in the prevention and treatment of acute graft versus host disease.
    Herve P
    Bone Marrow Transplant; 1991; 7 Suppl 2():117-9. PubMed ID: 1715225
    [No Abstract]   [Full Text] [Related]  

  • 47. Bone marrow transplantation in Basel: single center experience from 1973 to 1989.
    Speck B; Nissen C; Tichelli A; Roth J; Dazzi H; Stebler CH; Wernli M; Signer E; Gratwohl A
    Clin Transpl; 1989; ():115-22. PubMed ID: 2487556
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Cellular sorting methods in autologous (elimination of residual malignant cells) or allogeneic (T lymphocyte elimination) bone marrow grafts. Clinical pilot studies].
    Hervé P; Flesch M
    Nouv Rev Fr Hematol (1978); 1986; 28(2):97-105. PubMed ID: 2942838
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [HLA-mismatched bone marrow transplantation].
    Hiraoka A; Masaoka T
    Nihon Rinsho; 1990 Sep; 48(9):1994-2002. PubMed ID: 2232202
    [No Abstract]   [Full Text] [Related]  

  • 50. CD6+ donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors.
    Soiffer RJ; Weller E; Alyea EP; Mauch P; Webb IL; Fisher DC; Freedman AS; Schlossman RL; Gribben J; Lee S; Anderson KC; Marcus K; Stone RM; Antin JH; Ritz J
    J Clin Oncol; 2001 Feb; 19(4):1152-9. PubMed ID: 11181681
    [TBL] [Abstract][Full Text] [Related]  

  • 51. T cell depleted bone marrow transplantation in acute myeloblastic leukaemia: the way ahead.
    Prentice HG; Brenner MK; Gottlieb D
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():225-8. PubMed ID: 2653508
    [No Abstract]   [Full Text] [Related]  

  • 52. Selective depletion of CD8-positive T-lymphocytes for allogeneic bone marrow transplantation: engraftment, graft-versus-host disease and graft-versus leukemia.
    Champlin R; Giralt S; Przepiorka D; Ho W; Lee K; Gajewski J; Nimer S; Andersson B; Wallerstein R; Ippolito C
    Prog Clin Biol Res; 1992; 377():385-94; discussion 395-8. PubMed ID: 1438435
    [No Abstract]   [Full Text] [Related]  

  • 53. Laboratory control in predicting clinical efficacy of T cell-depletion procedures used for prevention of graft-versus-host disease: importance of limiting dilution analysis.
    Marciniak E; Romond EH; Thompson JS; Henslee PJ
    Bone Marrow Transplant; 1988 Nov; 3(6):589-98. PubMed ID: 3063328
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Bone marrow transplantation with T-cell depletion and hyperfractionated whole-body irradiation. The radiobiological and clinical correlations].
    Latini P
    Radiol Med; 1992 Apr; 83(4):445-52. PubMed ID: 1604003
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alloimmune effects of bone marrow transplantation for leukaemia on the leukaemic diseases.
    Marmont AM
    Bone Marrow Transplant; 1991; 7 Suppl 2():2-3. PubMed ID: 1878696
    [No Abstract]   [Full Text] [Related]  

  • 56. Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipients.
    Prentice HG; Blacklock HA; Janossy G; Gilmore MJ; Price-Jones L; Tidman N; Trejdosiewicz LK; Skeggs DB; Panjwani D; Ball S
    Lancet; 1984 Mar; 1(8375):472-6. PubMed ID: 6142207
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease.
    Aschan J; Ringdén O
    Clin Transplant; 1994 Jun; 8(3 Pt 1):258-70. PubMed ID: 8061365
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunotoxins for ex vivo bone marrow purging in human bone marrow transplantation.
    Vallera DA
    Cancer Treat Res; 1988; 37():515-35. PubMed ID: 2908642
    [No Abstract]   [Full Text] [Related]  

  • 59. Transplantation of T cell-depleted bone marrow in histoincompatible rabbits: improved engraftment and long-term chimeras after the addition of irradiated donor buffy coat cells and irradiated autologous cryopreserved bone marrow.
    Gratwohl A; Baldomero H; Nissen C; Speck B
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2756-7. PubMed ID: 3274587
    [No Abstract]   [Full Text] [Related]  

  • 60. Prevention of graft-versus-host disease in HLA-matched bone marrow transplantation for malignant diseases: a multicentric study of 62 patients using 3-pan-T monoclonal antibodies and rabbit complement.
    Racadot E; Hervé P; Beaujean F; Vernant JP; Flesch M; Plouvier E; Andreu G; Rio B; Philippe N; Souillet G
    J Clin Oncol; 1987 Mar; 5(3):426-35. PubMed ID: 3546617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.